ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 13 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E0N828 | Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N829 | Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N83Z | Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N86Z | Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N87Z | Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8BZ | Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8GC | Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8HZ | Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8KZ | Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8SF | Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N8TZ | Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P05Z | Introduction of Adhesion Barrier into Female Reproductive, Open Approach | Valid |
| 3E0P304 | Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P305 | Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P30M | Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P328 | Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P329 | Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P33Z | Introduction of Anti-inflammatory into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P35Z | Introduction of Adhesion Barrier into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P36Z | Introduction of Nutritional Substance into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P37Z | Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3BZ | Introduction of Anesthetic Agent into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3GC | Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3HZ | Introduction of Radioactive Substance into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3KZ | Introduction of Other Diagnostic Substance into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3LZ | Introduction of Sperm into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3Q0 | Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3Q1 | Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3SF | Introduction of Other Gas into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3TZ | Introduction of Destructive Agent into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P3VZ | Introduction of Hormone into Female Reproductive, Percutaneous Approach | Valid |
| 3E0P45Z | Introduction of Adhesion Barrier into Female Reproductive, Percutaneous Endoscopic Approach | Valid |
| 3E0P4GC | Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approach | Valid |
| 3E0P704 | Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P705 | Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P70M | Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P728 | Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P729 | Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P73Z | Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P76Z | Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P77Z | Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7BZ | Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7GC | Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7HZ | Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7KZ | Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7LZ | Introduction of Sperm into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7Q0 | Introduction of Autologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7Q1 | Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7SF | Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7TZ | Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P7VZ | Introduction of Hormone into Female Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0P804 | Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P805 | Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P80M | Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P828 | Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P829 | Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P83Z | Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P86Z | Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P87Z | Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8BZ | Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8GC | Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8HZ | Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8KZ | Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8SF | Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0P8TZ | Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0Q004 | Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q005 | Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q00M | Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q028 | Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q029 | Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q03Z | Introduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q06Z | Introduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q07Z | Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0AZ | Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0BZ | Introduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0E0 | Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0E1 | Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0GC | Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0HZ | Introduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0KZ | Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0NZ | Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0SF | Introduction of Other Gas into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q0TZ | Introduction of Destructive Agent into Cranial Cavity and Brain, Open Approach | Valid |
| 3E0Q304 | Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q305 | Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q30M | Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q328 | Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q329 | Introduction of Other Anti-infective into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q33Z | Introduction of Anti-inflammatory into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q36Z | Introduction of Nutritional Substance into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q37Z | Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q3AZ | Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q3BZ | Introduction of Anesthetic Agent into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q3E0 | Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q3E1 | Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach | Valid |
| 3E0Q3GC | Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Percutaneous Approach | Valid |